SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of White River Capital, Inc. (RVR), BioMimetic Therapeutics Inc. (BMTI) , Jeffries Group, Inc. (JEF) and Provectus Pharmaceuticals, Inc. (PVCT)
NEW YORK, Nov. 21, 2012 /PRNewswire/ --
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )
White River Capital, Inc.
Levi & Korsinsky is investigating the Board of Directors of White River Capital, Inc. (NYSE MKT: RVR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company and its subsidiary, Coastal Credit, LLC, to an affiliate of Parthenon Capital Partners for $23 per share.
Click here to learn more about the investigation http://zlk.9nl.com/white-river-capital-rvr.
BioMimetic Therapeutics Inc.
Levi & Korsinsky is investigating the Board of Directors of BioMimetic Therapeutics Inc. (NasdaqGS: BMTI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Wright Medical Group Inc. (NasdaqGS: WMGI) under which shareholders BioMimetic shareholders will receive $1.50 in cash and 0.2482 shares of Wright common stock for each share of BioMimetic stock they own.
Click here to learn more about the investigation http://zlk.9nl.com/biomimetic-bmti.
Jeffries Group, Inc.
Levi & Korsinsky is investigating the Board of Directors of Jeffries Group, Inc. (NYSE: JEF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to its largest shareholder, Leucadia National Corp. (NYSE: LUK) under which shareholders will receive 0.81 Leucadia shares for each share of Jefferies stock they own, representing an approximate value of $17.24 per share. At least one analyst set a price target of $19.00 per Jefferies share.
Click here to learn more about the investigation http://zlk.9nl.com/jefferies-group-jef, or call: 877-363-5972.
Provectus Pharmaceuticals, Inc.
Levi & Korsinsky, LLP is investigating Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), and its Board of Directors in connection with the compensation provided to certain of its executive officers.
To get more information, click here: http://zlk.9nl.com/provectus-pharmaceuticals-pvct, or call: 877-363-5972
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP
RELATED LINKS
http://www.zlk.com
More by this Source
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated
May 17, 2013, 12:52 ET
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Star Scientific, Inc. of Class Action Lawsuit and the Deadline of May 24, 2013 to Seek a Lead Plaintiff Position
May 14, 2013, 13:10 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Market Leader, Inc. in Connection with the Sale of the Company to Trulia, Inc.
May 10, 2013, 12:54 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.